Birch Hill Investment Advisors Lowered Its Stake in Celgene (CELG) as Share Price Rose; Pdt Partners Has Lifted Its Holding in 3 (DDD) by $1.73 Million


Pdt Partners Llc increased its stake in 3 (DDD) by 360.43% based on its latest 2019Q1 regulatory filing with the SEC. Pdt Partners Llc bought 173,001 shares as the company’s stock declined 34.95% while stock markets rallied. The hedge fund held 221,000 shares of the prepackaged software company at the end of 2019Q1, valued at $2.38M, up from 47,999 at the end of the previous reported quarter. Pdt Partners Llc who had been investing in 3 for a number of months, seems to be bullish on the $987.21 million market cap company. The stock increased 1.44% or $0.12 during the last trading session, reaching $8.46. About 879,728 shares traded. 3D Systems Corporation (NYSE:DDD) has declined 28.72% since June 21, 2018 and is downtrending. It has underperformed by 33.15% the S&P500. Some Historical DDD News: 14/03/2018 – 3D SYSTEMS 4Q REV. $177.3M, PRELIM. $176M-$178M; 10/05/2018 – 3D SYSTEMS – COLLABORATION WITH HUNTINGTON INGALLS’ NEWPORT NEWS SHIPBUILDING UNIT TO QUALIFY METAL ADDITIVE MANUFACTURING TECH TO BUILD NAVAL WARSHIPS; 16/03/2018 – 3D SYSTEMS CORP DDD.N : DEUTSCHE BANK RAISES TARGET PRICE TO $13 FROM $9; 14/03/2018 – 3D Systems 4Q Adj EPS 5c; 02/04/2018 – 3D Systems Delivering on Prototyping to Production Promise – Highlighting Customer Applications at AMUG 2018; 02/05/2018 – 3D Systems 1Q Loss/Shr 19c; 02/05/2018 – 3D SYSTEMS 1Q ADJ LOSS/SHR 3C, EST. EPS 1C; 18/04/2018 – Artec 3D Announces Integration of Handheld Scanners with 3D Systems’ Geomagic Freeform; 21/05/2018 – 3D Systems’ NextDent™ 5100 Named 2018 Healthcare Application of the Year by Additive Manufacturing Publication ‘3D Printing Industry’; 14/03/2018 – 3D Systems 4Q Rev $177.3M

Birch Hill Investment Advisors Llc decreased its stake in Celgene Corp (CELG) by 24.06% based on its latest 2019Q1 regulatory filing with the SEC. Birch Hill Investment Advisors Llc sold 13,996 shares as the company’s stock rose 5.82% with the market. The institutional investor held 44,172 shares of the major pharmaceuticals company at the end of 2019Q1, valued at $4.17 million, down from 58,168 at the end of the previous reported quarter. Birch Hill Investment Advisors Llc who had been investing in Celgene Corp for a number of months, seems to be less bullish one the $69.21 billion market cap company. The stock increased 0.31% or $0.3 during the last trading session, reaching $98.13. About 4.06M shares traded. Celgene Corporation (NASDAQ:CELG) has risen 11.31% since June 21, 2018 and is uptrending. It has outperformed by 6.88% the S&P500. Some Historical CELG News: 26/04/2018 – Bristol-Myers’ cancer drug Opdivo fuels growth, but revenue falls short; 21/05/2018 – Slipping out the back door — BD chief George Golumbeski is the latest top exec to exit Celgene during management overhaul $CELG; 30/05/2018 – Celgene and Chinese Partner BeiGene Verge in Opposite Directions; 15/05/2018 – X4 Pharmaceuticals Presents Clinical Data Demonstrating Combinability of X4P-001-IO and Opdivo® (nivolumab) in Patients with; 23/04/2018 – ZYMEWORKS INC – CELGENE HAS EXERCISED ITS RIGHT TO INCREASE NUMBER OF POTENTIAL PRODUCTS IT CAN DEVELOP AND COMMERCIALIZE FROM EIGHT TO TEN; 10/04/2018 – FOCUS-Lonza’s virus factory shows gene therapy’s Texas-sized promise; 30/05/2018 – Denali Has Chosen to Exercise Early Option to Acquire Asset-Centric Vehicle F-Star Gamma Ltd; 28/03/2018 – AMAG Pharma engages Perella Weinberg to explore sale of Cord Blood Registry unit; 17/04/2018 – Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2; 26/04/2018 – Bristol-Myers 1Q Opdivo Revenue $1.51 Billion

More notable recent 3D Systems Corporation (NYSE:DDD) news were published by: Finance.Yahoo.com which released: “Is Nabors Industries Ltd. (NBR) A Good Stock To Buy ? – Yahoo Finance” on June 10, 2019, also Finance.Yahoo.com with their article: “Is 3D Systems Corporation (DDD) A Good Stock To Buy? – Yahoo Finance” published on May 02, 2019, Seekingalpha.com published: “3D Systems Q1 2019 Earnings Preview – Seeking Alpha” on May 06, 2019. More interesting news about 3D Systems Corporation (NYSE:DDD) were released by: Seekingalpha.com and their article: “3D Systems -18% on Q3 misses – Seeking Alpha” published on October 30, 2018 as well as Investorplace.com‘s news article titled: “Cronos Stock May Be the Least Trusted Name in Cannabis – Investorplace.com” with publication date: May 27, 2019.

Investors sentiment increased to 1.43 in 2019 Q1. Its up 0.44, from 0.99 in 2018Q4. It increased, as 13 investors sold DDD shares while 48 reduced holdings. 32 funds opened positions while 55 raised stakes. 80.47 million shares or 1.46% more from 79.31 million shares in 2018Q4 were reported. Westpac Banking Corporation reported 127,141 shares stake. Ironwood Financial Ltd Company owns 0% invested in 3D Systems Corporation (NYSE:DDD) for 110 shares. Pinnacle Assoc Limited accumulated 0% or 10,500 shares. Riverhead Capital Ltd stated it has 22,743 shares or 0.01% of all its holdings. Creative Planning stated it has 0% of its portfolio in 3D Systems Corporation (NYSE:DDD). Cibc World Markets has 12,711 shares. 852,517 were accumulated by Commerzbank Aktiengesellschaft Fi. Pub Employees Retirement Association Of Colorado stated it has 0% in 3D Systems Corporation (NYSE:DDD). Ls Limited Co reported 0.01% stake. River Mercantile Asset Limited Liability Partnership reported 445,384 shares. State Board Of Administration Of Florida Retirement Sys accumulated 75,577 shares. Cwm Limited Co stated it has 0% of its portfolio in 3D Systems Corporation (NYSE:DDD). Cubist Systematic Strategies Lc accumulated 10,766 shares. Millennium Mngmt Ltd Liability Com invested in 0% or 112,461 shares. Financial Bank Of New York Mellon accumulated 1.32M shares.

Pdt Partners Llc, which manages about $4.99B and $1.77B US Long portfolio, decreased its stake in Seaworld Entmt Inc (NYSE:SEAS) by 31,629 shares to 152,404 shares, valued at $3.93 million in 2019Q1, according to the filing. It also reduced its holding in Ra Pharmaceuticals Inc by 15,193 shares in the quarter, leaving it with 9,292 shares, and cut its stake in Ehealth Inc (NASDAQ:EHTH).

Investors sentiment increased to 0.76 in Q1 2019. Its up 0.12, from 0.64 in 2018Q4. It improved, as 108 investors sold CELG shares while 441 reduced holdings. 204 funds opened positions while 213 raised stakes. 482.72 million shares or 1.75% less from 491.33 million shares in 2018Q4 were reported. Fort LP holds 0.31% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 16,191 shares. 2.40 million are owned by Ruffer Llp. Ferguson Wellman Cap Mngmt accumulated 2,147 shares. Banque Pictet & Cie Sa has invested 0.74% of its portfolio in Celgene Corporation (NASDAQ:CELG). Wellington Group Llp invested 0% of its portfolio in Celgene Corporation (NASDAQ:CELG). Parkside State Bank Tru has invested 0.02% in Celgene Corporation (NASDAQ:CELG). Amundi Pioneer Asset Management invested in 778,452 shares. 3,795 are owned by Benjamin F Edwards. Teachers Retirement Systems Of The State Of Kentucky has 487,610 shares for 0.57% of their portfolio. Argent Trust owns 26,672 shares. Private Wealth invested in 11,851 shares. 48 are owned by Lifeplan. Texas-based Callahan Advisors Limited Liability Company has invested 0.51% in Celgene Corporation (NASDAQ:CELG). Zwj Inv Counsel reported 233,779 shares or 1.82% of all its holdings. Atria Invests Ltd Liability accumulated 16,339 shares.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 25. They expect $2.45 EPS, up 31.72% or $0.59 from last year’s $1.86 per share. CELG’s profit will be $1.73 billion for 10.01 P/E if the $2.45 EPS becomes a reality. After $2.28 actual EPS reported by Celgene Corporation for the previous quarter, Wall Street now forecasts 7.46% EPS growth.

Birch Hill Investment Advisors Llc, which manages about $1.24B and $1.31 billion US Long portfolio, upped its stake in Bank Amer Corp (NYSE:BAC) by 21,450 shares to 1.17 million shares, valued at $32.23 million in 2019Q1, according to the filing. It also increased its holding in Schlumberger Ltd (NYSE:SLB) by 373,241 shares in the quarter, for a total of 444,640 shares, and has risen its stake in Cvs Health Corp (NYSE:CVS).

Since February 7, 2019, it had 0 insider purchases, and 1 insider sale for $2.05 million activity.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Nasdaq.com which released: “Top 5 ROE Stocks to Buy as US-Mexico Trade Concerns Abate – Nasdaq” on June 11, 2019, also 247Wallst.com with their article: “Big Biotechs Have Short Sellers on the Run – 24/7 Wall St.” published on June 12, 2019, Seekingalpha.com published: “bluebird bio: Returning To A Previous Winner – Seeking Alpha” on June 20, 2019. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Nasdaq.com and their article: “Insys Down on Bankruptcy News Amid Increasing Legal Expenses – Nasdaq” published on June 11, 2019 as well as Streetinsider.com‘s news article titled: “Celgene (CELG), Acceleron Pharma (XLRN) Announce FDA Accepts Luspatercept BLA in Myelodysplastic Syndromes and Beta-Thalassemia – StreetInsider.com” with publication date: June 04, 2019.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

Leave a Reply